Table 1.
Characteristics of study population among those with and without CKDa
| Characteristic | CKD (29%) | No CKD (71%) |
|---|---|---|
| Age (yr; n [%]) | ||
| <45 | 636 (0.9) | 10,737 (6.1) |
| 45 to 59 | 12,432 (17.4) | 74,827 (42.6) |
| 60 to 74 | 28,395 (39.6) | 57,607 (32.8) |
| ≥75 | 30,203 (42.1) | 32,339 (18.4) |
| Male (n [%]) | 69,338 (96.8) | 167,692 (95.6) |
| Black (n [%]) | 11,450 (16.0) | 34,098 (19.4) |
| GFR (ml/min per 1.73 m2; mean [SD]) | 42.5 (14.0) | 87.9 (22.5) |
| Diabetes (n [%]) | 37,130 (51.8) | 60,360 (34.4) |
| CVD (n [%])b | 43,589 (60.8) | 61,871 (35.3) |
| Cancer (n [%])c | 21,742 (30.3) | 45,814 (26.1) |
| Charlson Comorbidity Index (n [%]) | ||
| 0 to 1 | 12,652 (17.7) | 64,926 (37.0) |
| 2 to 3 | 22,434 (31.3) | 57,846 (33.0) |
| ≥4 | 36,580 (51.0) | 52,738 (30.1) |
| LOS (d; n [%]) | ||
| <3 days | 24,337 (34.0) | 67,941 (38.7) |
| ≥3 | 47,329 (66.0) | 107,569 (61.3) |
| eGFR (n [%]) | ||
| ≥60 | 176,020 (100) | |
| 45 to <60 | 37,768 (53.1) | |
| 30 to <45 | 20,268 (28.5) | |
| <30 | 13,120 (18.4) |
a
All comparisons were significant at P < 0.001.
b
One or more of the following: Congestive heart failure, coronary artery disease, or cerebrovascular disease.
c
Excluding nonmelanomatous skin cancer.